To authorize the use of experimental drugs, biological products, and devices by patients diagnosed with a terminal illness in accordance with State law, and for other purposes.

United States115e CongrèsHR-2368House of Representatives
Mis à jour : 7 juin 2017

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Introduced (House)Consulter le texte officiel

1 version disponible

Tous les dossiers disponibles sont affichés.

Chronologie

  1. Introduced in House

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    House of Representatives

  4. Referred to the Subcommittee on the Constitution and Civil Justice.

    House of Representatives